Balamuthusamy Saravanan, Nguyen Peter, Bireddy Suman, Vallurapalli Avinash, Jalandhara Nishant, Afolabi Dapo
Tarrant Vascular Access Center, Vascular and Interventional Nephrology, Fort Worth, Texas - USA.
Nephrology Division, Department of Medicine, University of North Texas, Fort Worth, Texas - USA.
J Vasc Access. 2016 May 7;17(3):233-8. doi: 10.5301/jva.5000529. Epub 2016 Mar 15.
This study compared the patency of a split-tip self-centering catheter with a predesigned curve (CentrosFLO; Merit, Salt Lake City, Utah) and a standard split-tip catheter with straight distal limbs (Medcomp, Harleysville, Pennsylvania) catheter in patients requiring exchange of a dysfunctional tunneled dialysis catheter (TDC).
A single-center retrospective chart review was performed between January 2013 and July 2014. Patients had an existing dysfunctional TDC that was exchanged over a wire using the same access site for either a split-tip self-centering catheter with a predesigned curve or a standard split-tip catheter with straight distal limbs catheter. The primary endpoint was catheter patency analyzed at 1, 3, and 6 months after initial exchange.
A total of 73 patients met inclusion criteria (46 in the self-centering catheter group and 27 in the standard split-tipped group). Mean durations of the exchanged catheters were similar between groups. The mean 1-, 3-, and 6-month patency rates for the self-centering and split-tip catheters were 89%, 67.4%, and 23.9% and 81.5%, 40.7%, and 14.8%, respectively. Mean blood flow rates (BFRs) were similar between groups at 1 and 3 months; however, at 6 months, mean rates were 388 mL/min versus 352 mL/min for the self-centering group and split-tipped group, respectively (p<0.01).
These results demonstrate improved patency with the CentrosFLO self-centering catheter versus the split-tip catheter. This may be due to the unique design of the self-centering catheter, allowing for preserved BFRs and patency. These results should be further explored in prospective, randomized multicenter studies.
本研究比较了一种具有预先设计曲线的分叉尖端自定心导管(CentrosFLO;Merit公司,犹他州盐湖城)与一种远端肢体为直型的标准分叉尖端导管(Medcomp公司,宾夕法尼亚州哈雷斯维尔)在需要更换功能失调的隧道式透析导管(TDC)的患者中的通畅情况。
2013年1月至2014年7月进行了一项单中心回顾性病历审查。患者有一根现有的功能失调的TDC,通过同一穿刺部位在导丝引导下更换为具有预先设计曲线的分叉尖端自定心导管或远端肢体为直型的标准分叉尖端导管。主要终点是在首次更换后1、3和6个月分析导管通畅情况。
共有73例患者符合纳入标准(自定心导管组46例,标准分叉尖端导管组27例)。两组更换导管的平均使用时间相似。自定心导管和分叉尖端导管的1个月、3个月和6个月平均通畅率分别为89%、67.4%和23.9%以及81.5%、40.7%和14.8%。两组在1个月和3个月时的平均血流量(BFR)相似;然而在6个月时,自定心组和分叉尖端组的平均血流量分别为388 mL/分钟和352 mL/分钟(p<0.01)。
这些结果表明,与分叉尖端导管相比,CentrosFLO自定心导管的通畅情况有所改善。这可能是由于自定心导管的独特设计,使其能够保持BFR并维持通畅。这些结果应在前瞻性、随机多中心研究中进一步探讨。